Novel transcript, antisense to SP110 (ENSG00000225963)

"Novel transcript, antisense to SP110" (ENSG00000225963) is a long non-coding RNA overlapping the SP110 gene on the opposite DNA strand. As a natural antisense transcript, it is classified as a lncRNA, and may post-transcriptionally or epigenetically regulate SP110 expression through mechanisms common to antisense RNAs such as transcriptional interference, RNA masking, or RNA-directed silencing. There is currently no evidence that this lncRNA has a direct biological, disease, or therapeutic role, and it is not a canonical target in drug discovery or diagnostics[1][3][5]. If structured target data is required for drugs, receptors, enzymes, or similar molecular entities, this entry should be excluded or flagged, as it does not fit such classifications.

Other names

AC009950.2ENSG00000225963

Not applicable; no drugs are known to target this molecule. Mechanistically, natural antisense transcripts can regulate gene expression by various mechanisms such as transcriptional interference, RNA masking, involvement in RNAi pathways, or epigenetic modifications